Recent Quotes (30 days)

You have no recent quotes
chg | %

Medmira Inc  

(Public, CVE:MIR)   Watch this stock  
Find more results for MIR
+0.0050 (6.25%)
Apr 16 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.09 - 0.09
52 week 0.05 - 0.14
Open 0.09
Vol / Avg. 10,500.00/207,378.00
Mkt cap 43.72M
P/E     -
Div/yield     -
EPS 0.00
Shares 514.36M
Beta 0.30
Inst. own     -

Key stats and ratios

Q4 (Oct '13) 2013
Net profit margin -177.51% -20.10%
Operating margin -124.13% -72.43%
EBITD margin - -106.15%
Return on average assets -97.65% -19.45%
Return on average equity - -
Employees 65 -
CDP Score - -


Suite 1, 155 Chain Lake Drive
+1-902-4501588 (Phone)
+1-902-4501580 (Fax)

Website links


MedMira Inc.( MedMira) is a biotechnology company. The Company is engaged in the development and commercialization of diagnostics and technology platforms. The Company operates in North America, Latin America/Caribbean, Europe and Asia Pacific. It invests in research. The Company�s tests provide hospitals, labs, clinics and individuals with instant diagnosis for diseases, such as HIV and hepatitis C in just three steps. The Company�s tests are sold under the Reveal, Multiplo and Miriad brands. The Company sells its tests through a worldwide network of medical distributors and strategic business development partners with customers in all sectors of the healthcare industry, including laboratories, hospitals, point-of-care facilities, governments, and public health agencies.

Officers and directors

Hermes Chan President, Chief Executive Officer, Director
Jelle Kuypers Chief Financial Officer
Sing Chan Chief Operating Officer
Michael Sidler Director
Markus M. Meile Independent Director
Romano Robusto Independent Director
Shou-Ching Tang M.D. Independent Director